Full text
| |
| Author(s): |
Camila Figueira Mendes
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI) |
| Defense date: | 2012-03-19 |
| Examining board members: |
Estela Maris Andrade Forell Bevilacqua;
Débora Cristina Damasceno;
Vanessa Morais Freitas
|
| Advisor: | Estela Maris Andrade Forell Bevilacqua |
| Abstract | |
Nowadays, the use of medicinal plants has grown dramatically. In Brazil, a country whose native flora is rich, has invested substantially in research in this area. This is due in part to the need for new drugs, the interest in marketing these products, the interest in the preservation of popular culture and the reserve of national flora. In parallel with this scenario is the belief that phitotherapeutics are harmless in special circumstances such as pregnancy, hypertension, diabetes, etc. It is as if the herbal acted specifically in a determinate disease not on the metabolism as a whole. The Mikania glomerata Sprengel, popularly known as guaco and originating from South America, is a plant undergrowth, which rises in the forests and savannahs, and that lends itself very well to domestic cultivation. It is widely used by local people in the treatment of diseases such as asthma, bronchitis, and rheumatism, as well as having antifungal effect, antimicrobial, antiallergic, anti-inflammatory and anti-snakebite, in most cases administered without the supervision of health professionals. In this study, our goal is to study the possible action of plant extract of Mikania glomerata Sprengel (guaco) in pregnancy and reproductive profile of mice (Mus musculus domesticus) and determine whether the administration of this drug may affect the embryo / fetus and placenta during pregnancy . This study showed that the use of extract of Mikania glomerata at supratherapeutic doses can act on morphofunctional organic processes, interfering with fetal and placental growth and could lead to pregnancy failure as well as contribute to the appearance of birth defects. Furthermore, the decrease in fetal growth observed in therapeutic doses is also considered a warning to the inadvertent use of the extract guaco without medical supervision because, at any gestational period. (AU) | |
| FAPESP's process: | 09/06655-3 - Effect of Mikania glomerata Sprengel (Guaco)extract on implantation, placental and embryonic development in mice. |
| Grantee: | Camila Figueira Mendes |
| Support Opportunities: | Scholarships in Brazil - Master |